Insulin-cortisol interaction in depression and other neurological diseases: An alternative hypothesis

Psychoneuroendocrinology

Volumn 32, Issue 7, 2007, Pages 854-855

  Castillo Quan, Jorge I ^a,b   Herrera González, Alejandro ^b,c,d   Pérez Osorio, Julia M ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b Metabolic Syndrome Psychoneuroendocrinology Study Group (Grupo de Estudio de Neuropsico Endocrinolog   (Mexico)

^c Universidad del Mayab   (Mexico)

^d Neuropsychology and Psychotherapy Service   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INSULIN; ROSIGLITAZONE;

ALZHEIMER DISEASE; COGNITIVE DEFECT; DEPRESSION; DRUG INHIBITION; HUMAN; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPERINSULINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN RELEASE; INSULIN RESISTANCE; LETTER; METABOLIC SYNDROME X; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL;

DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; HYDROCORTISONE; HYPERINSULINISM; INSULIN; METABOLIC SYNDROME X; NERVOUS SYSTEM DISEASES;

EID: 34547562949     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.04.013     Document Type: Letter

References (12)

1. Castillo-Quan, J.I., Perez-Osorio, J.M., 2007. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications (Letter). Diabetes Care 30, e49, doi:10.2337/dc07-0104.
2. Chiodini I., Adda G., Scillitani A., Coletti F., Morelli V., Di Lembo S., Epaminonda P., Masserini B., Beck-Peccoz P., Orsi E., Ambrosi B., and Arosio M. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care 30 (2007) 83-88
3. Everson-Rose S.A., Meyer P.M., Powell L.H., Pandey D., Torréns J.I., Kravitz H.M., Bromberger J.T., and Matthews K.A. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27 (2004) 2856-2862
4. Figlewicz D.P., Brot M.D., McCall A.L., and Szot P. Diabetes causes differential changes in CNS noradrenergic and dopaminergic neurons in the rat: a molecular study. Brain Res. 736 (1996) 54-60
5. Fruehwald-Schultes B., Kern W., Bong W., Wellhoener P., Kerner W., Born J., Fehm H.L., and Peters A. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J. Clin. Endocrinol. Metab. 84 (1999) 3041-3046
6. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., and LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci. 26 (2006) 9047-9056
7. Katon W., von Korff M., Ciechanowski P., Russo J., Lin E., Simon G., Ludman E., Walker E., Bush T., and Young B. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 27 (2004) 914-920
8. Mielke J.G., Taghibiglou C., Liu L., Zhang Y., Jia Z., Adeli K., and Wang Y.T. A biochemical and functional characterization of diet-induced brain insulin resistance. J. Neurochem. 93 (2005) 1568-1578
9. Pedersen W.A., McMillan P.J., Kulstad J.J., Leverenz J.B., Craft S., and Haynatzki G.R. Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice. Exp. Neurol. 199 (2006) 265-273
10. Rowland N.E., and Bellush L.L. Diabetes mellitus: stress, neurochemistry and behavior. Neurosci. Biobehav. Rev. 13 (1989) 199-206
11. Timonen M., Rajala U., Jokelainen J., Keinänen-Kiukaanniemi S., Meyer-Rochow V.B., and Räsänen P. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finand 1966 birth control. Mol. Psychiatry 11 (2006) 929-933
12. Vogelzangs N., Suthers K., Ferrucci L., Simonsick E.M., Ble A., Schrager M., Bandinelli S., Lauretani F., Giannelli S.V., and Penninx B.W. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 32 (2007) 151-159